Two Held In Assam With 20,000 Yaba Tablets Worth Rs 4 Crore

Cachar: In a joint operation, police and Central Reserve Police Force (CRPF) on Sunday seized 20,000 Yaba tablets worth Rs 4 crore in Assam’s Cachar district and arrested two drug peddlers, officials said. Numal Mahatta, Superintendent of Police of Cachar district said that, based on specific intelligence input, an operation was conducted on Sunday against the transportation of illegal drugs in the Silchar area.

“Cachar district police and B/147 BN CRPF arrested two persons with 20,000 yaba tablets. The market value of the seized drugs is estimated at around Rs 4 crore,” Numal Mahatta said. The arrested persons were identified as Samsuddin Borbhuyan (30) and Samim Ahmed Borbhuyan (30). Further investigation is on.

Earlier in a joint operation with Manipur Police, Assam Rifles recovered over 1 kg of psychotropic drug WY tablets and apprehended one person, officials said on Saturday. As per officials, the seizure was made on Friday. “A total of 1.137 kg of psychotropic drug WY tablets of approximate cost Rs 1.5 crore was recovered from the bordering area of Assam and Manipur,” they said.

The apprehended person, along with the seized drugs, was handed over to Jiribam Police for further investigation and legal proceedings. An investigation is underway. Further details are awaited.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre